GRI Bio, Inc. — Director's Dealing 2023

Aug 14, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GRI BIO, Inc. (GRI)
CIK: 0001824293
Period of Report: 2023-08-10

Reporting Person: Rongen Roelof (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-10	Stock Option (Right to Buy)	$2.90	A	34483	Acquired	2033-08-10	Common Stock (34483)	Direct

Footnotes

F1: Vests as to 1/12th of the underlying shares of common stock on the date of grant, then in 11 equal quarterly installments such that the stock option is fully vested on the third annual anniversary of the date of grant.